Arkolith/Insider Trading/RVPH/Form 4

Bhat Laxminarayan

President and CEO, Director, 10% OwnerREVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) · full profile →Form 4 · filed Feb 18, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 13, 2025Grant(A)182K—$0182K
Feb 13, 2025Grant(A)519K—$0519K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-25-004220) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML